Consistent with this high efficacy, expression of the MGMT (O6-methylguanine–DNA methyltransferase) DNA-repair protein, a major contributor to TMZ resistance [25] was undetectable in the patient tumor (Fig S1U). Here, XRCC6P5 is linked to neoplasm.